Blue Ox Healthcare Partners
PE / VC · New York · United States
Stages
Investment region
Industries
Profile
Blue Ox Healthcare Partners is a growth equity firm based in New York, founded in 2009. The firm specializes in healthcare investments, focusing on technology-enabled innovations that drive precision health. With a team of five professionals, Blue Ox leverages its deep industry knowledge to guide companies through the commercialization process, aiming to improve healthcare outcomes by addressing patients as individuals. The firm invests in growth-stage companies within the healthcare services, health technology, and life sciences sectors. Blue Ox targets commercial-ready innovations in precision health, healthcare delivery, and affordability. They typically invest in companies that are ready to scale, providing both capital and strategic guidance. The firm manages Blue Ox Healthcare Partners Fund 1, which has an AUM of $50 million. Notable investments by Blue Ox include Sera Prognostics, a proteomic diagnostic platform; Epic Sciences, a liquid biopsy platform; and Gemelli Biotech, which focuses on precision diagnostics for GI diseases. These investments reflect Blue Ox's commitment to advancing healthcare technologies that offer significant improvements in patient care and cost management.
担当者 (2)
| Name | Title | 電話 | ||
|---|---|---|---|---|
| Managing Partner | — | — | — | |
| Managing Partner Blue Ox | — | — | — |
Name, email and phone are partially hidden. Subscribe to see them in full.